ERBB2 and breast carcinoma: The mechanism is determined using breast cancer BT-474 and SKBR-3 cells indicating that vorinostat causes heat-shock protein 90 (HSP90) acetylation, which leads to the dissociation of HSP90 from HER2, thereby resulting in polyubiquitin chain synthesis and HER2 degradation [76].